{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-21-039510","form_type":"8-K","ticker":"IONS","cik":"0000874015","company_name":"IONIS PHARMACEUTICALS INC","filed_at":"2021-11-26T23:59:59+00:00","discovered_at":"2026-05-14T18:04:15.930013+00:00","generated_at":"2026-06-28T05:22:56.369977+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Director Peter Reikes resigns from Ionis board to join FDA, effective Nov 21, 2021","bullets":["Peter N. Reikes resigned from the Board of Directors effective November 21, 2021.","Resignation due to accepting a position with the U.S. Food and Drug Administration to avoid a perception of conflict of interest.","No successor has been named to fill the vacancy on the Board.","Company expressed gratitude for Reikes' advice and leadership as a Board member."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-21-039510","json":"https://secwatch.observer/filing/0001140361-21-039510.json","markdown":"https://secwatch.observer/filing/0001140361-21-039510.md","text":"https://secwatch.observer/filing/0001140361-21-039510.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/874015/000114036121039510/0001140361-21-039510-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/874015/000114036121039510/brhc10031117_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T05:22:56.369977+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"00bf4cad7d","claim":"Peter N. Reikes resigned as Director at IONIS PHARMACEUTICALS INC.","evidence_excerpt":"On November 19, 2021, Peter N. Reikes, a member of the Board of Directors (“Board”) and Finance Committee of the Board of Ionis Pharmaceuticals, Inc. (the “Company”), notified the Company that he is resigning from the Company’s Board effective November 21, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/874015/000114036121039510/0001140361-21-039510-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}